As far as I know, you can't sell a stock unless there is someone willing to buy it. Someone believes this stock is going back up. We will just have to wait and see that someone is.
This has to be the stupidest post ever. You are saying that people with dementia have the mental capacity to be influenced by a pill. I don't think they understand that they are even taking a pill. Apparently you have never been around a person with dementia.
Adam M. Klein, MD, FACS
Dr. Adam Klein
Adam M. Klein, MD, FACS, who started practicing at Emory in 2005, is Assistant Professor, Otolaryngology – Head and Neck Surgery, at The Emory Voice Center, Emory University Hospital Midtown.
Laryngology (Completed fellowship training in 2005)
Otolaryngology (Board certified in 2005)
Areas of Expertise
Care of the Professional Voice
It bothers me that not one new media outlet has said a word about this. I know it is a weekend but in this age of instant news we should have heard something.
The FDA will respond tonight. It will be up to the company to issue the press release. The FDA doesn't miss their due dates.
I would think that Medicare, Medicaid, and the insurance companies would make or break this cologuard rather than any advisory committee. I don't see why those folks would want to spend thousands of dollars when there is a cheaper 'Alternate" method to accomplish the same purpose.
I was under the impression that congress had given the FDA authority to approve a drug if the drug
was beneficial and did no harm for diseases that have no current healing effects. Why wouldn't the FDA just go ahead an approve SRPT's drug now based on the data we heard today? I see no reason for the FDA to allow these boys to continue to suffer like they are today. If we don't hear from the FDA by the end of next week, call your congressmen.